1999PubMedRequires access

[The treatment of vaginal mycosis with Orungal].

B Pekhlivanov, Roumiana Markova

Open publisher page 0 citations

Abstract

UNLABELLED: The authors report their results of the treatment of the vaginal mycosis with Orungal (Janssen-Cilag). Twenty two sexually active women are included in the study, all with clinical signs of fungal vaginitis. Microscopic examination of vaginal secretions and fungal cultures are performed for all of the patients. Twenty cultures show C.albicans as causing agent and 2-non-C.albicans. One-day treatment with Orungal 2 x 200 mg is prescribed. Control examination and mycologic cultures are performed on day 7-10 and 30 after treatment. In 20 patients (91%) there is not clinical signs and the cultures remains negatives. In 2 (9%) the signs of fungal vaginitis persists which evoke the giving of the same dose once again. Adverse reaction (nausea) has been notify by one woman. CONCLUSION: The treatment with Orungal of the vaginal mycosis is highly effective, with minimal adverse reactions and very good acceptance by women.

About this research paper

What this paper is about

UNLABELLED: The authors report their results of the treatment of the vaginal mycosis with Orungal (Janssen-Cilag). Twenty two sexually active women are included in the study, all with clinical signs of fungal vaginitis. Microscopic examination of vaginal secretions and fungal cultures are performed for all of the patients. Twenty cultures show C.albicans as causing agent and 2-non-C.albicans. One-day treatment with Orungal 2 x 200 mg is prescribed. Control examination and mycologic cultures are performed on day 7-10 and 30 after treatment. In 20 patients (91%) there is not clinical signs and the cultures remains negatives. In 2 (9%) the signs of fungal vaginitis persists which evoke the giving of the same dose once again. Adverse reaction (nausea) has been notify by one woman. CONCLUSION: The treatment with Orungal of the vaginal mycosis is highly effective, with minimal adverse reactions and very good acceptance by women.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

UNLABELLED: The authors report their results of the treatment of the vaginal mycosis with Orungal (Janssen-Cilag). Twenty two sexually active women are included in the study, all with clinical signs of fungal vaginitis. Microscopic examination of vaginal secretions and fungal cultures are performed for all of the patients. Twenty cultures show C.albicans as causing agent and 2-non-C.albicans. One-day treatment with Orungal 2 x 200 mg is prescribed. Control examination and mycologic cultures are performed on day 7-10 and 30 after treatment. In 20 patients (91%) there is not clinical signs and the cultures remains negatives. In 2 (9%) the signs of fungal vaginitis persists which evoke the giving of the same dose once again. Adverse reaction (nausea) has been notify by one woman. CONCLUSION: The treatment with Orungal of the vaginal mycosis is highly effective, with minimal adverse reactions and very good acceptance by women.

Key concepts: Vaginitis, Mycosis, Medicine, Vaginal disease, Candida albicans, Adverse effect, Nausea, Dermatology

Related papers

Back to paper searchBrowse research topicsOriginal source
[The treatment of vaginal mycosis with Orungal]. — Research Paper | ScholarLens